1. Home
  2. BWAY vs XNET Comparison

BWAY vs XNET Comparison

Compare BWAY & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • XNET
  • Stock Information
  • Founded
  • BWAY 2003
  • XNET 2003
  • Country
  • BWAY Israel
  • XNET China
  • Employees
  • BWAY N/A
  • XNET N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • XNET Computer Software: Prepackaged Software
  • Sector
  • BWAY Health Care
  • XNET Technology
  • Exchange
  • BWAY Nasdaq
  • XNET Nasdaq
  • Market Cap
  • BWAY 159.3M
  • XNET 131.8M
  • IPO Year
  • BWAY 2019
  • XNET 2014
  • Fundamental
  • Price
  • BWAY $10.00
  • XNET $1.87
  • Analyst Decision
  • BWAY Strong Buy
  • XNET
  • Analyst Count
  • BWAY 3
  • XNET 0
  • Target Price
  • BWAY $13.17
  • XNET N/A
  • AVG Volume (30 Days)
  • BWAY 88.8K
  • XNET 119.6K
  • Earning Date
  • BWAY 11-12-2024
  • XNET 11-14-2024
  • Dividend Yield
  • BWAY N/A
  • XNET N/A
  • EPS Growth
  • BWAY N/A
  • XNET 23.02
  • EPS
  • BWAY 0.04
  • XNET 0.23
  • Revenue
  • BWAY $38,631,000.00
  • XNET $359,611,000.00
  • Revenue This Year
  • BWAY $378.91
  • XNET N/A
  • Revenue Next Year
  • BWAY $20.27
  • XNET N/A
  • P/E Ratio
  • BWAY $122.14
  • XNET $8.27
  • Revenue Growth
  • BWAY 34.19
  • XNET N/A
  • 52 Week Low
  • BWAY $4.61
  • XNET $1.45
  • 52 Week High
  • BWAY $10.98
  • XNET $2.41
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 53.76
  • XNET 44.55
  • Support Level
  • BWAY $8.96
  • XNET $2.01
  • Resistance Level
  • BWAY $10.27
  • XNET $1.98
  • Average True Range (ATR)
  • BWAY 0.62
  • XNET 0.11
  • MACD
  • BWAY -0.06
  • XNET -0.03
  • Stochastic Oscillator
  • BWAY 57.76
  • XNET 11.99

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

Share on Social Networks: